397 related articles for article (PubMed ID: 17420420)
21. Androgenetic alopecia and insulin resistance in young men.
González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
[TBL] [Abstract][Full Text] [Related]
22. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
Ryu SY; Kim KS; Park J; Kang MG; Han MA
J Prev Med Public Health; 2008 Nov; 41(6):413-8. PubMed ID: 19037171
[TBL] [Abstract][Full Text] [Related]
23. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
[TBL] [Abstract][Full Text] [Related]
24. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
Ragab A; Abousamra NK; Higazy A; Saleh O
Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
[TBL] [Abstract][Full Text] [Related]
25. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study.
Pérez-Tasigchana RF; León-Muñoz LM; Lopez-Garcia E; Gutierrez-Fisac JL; Laclaustra M; Rodríguez-Artalejo F; Guallar-Castillón P
Age Ageing; 2017 Sep; 46(5):807-812. PubMed ID: 28338890
[TBL] [Abstract][Full Text] [Related]
27. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
28. Multiple biomarkers and their relative contributions to identifying metabolic syndrome.
Lee JG; Lee S; Kim YJ; Jin HK; Cho BM; Kim YJ; Jeong DW; Park HJ; Kim JE
Clin Chim Acta; 2009 Oct; 408(1-2):50-5. PubMed ID: 19622349
[TBL] [Abstract][Full Text] [Related]
29. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.
Park HT; Cho GJ; Ahn KH; Shin JH; Hong SC; Kim T; Hur JY; Kim YT; Lee KW; Kim SH
Maturitas; 2009 Mar; 62(3):301-5. PubMed ID: 19250778
[TBL] [Abstract][Full Text] [Related]
30. Role of frailty in patients with cardiovascular disease.
Afilalo J; Karunananthan S; Eisenberg MJ; Alexander KP; Bergman H
Am J Cardiol; 2009 Jun; 103(11):1616-21. PubMed ID: 19463525
[TBL] [Abstract][Full Text] [Related]
31. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
Matsushita K; Tamakoshi K; Yatsuya H; Wada K; Otsuka R; Takefuji S; Hotta Y; Kondo T; Murohara T; Toyoshima H
Int J Cardiol; 2008 Mar; 124(3):339-44. PubMed ID: 17433469
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius.
Boyko EJ; Shaw JE; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
J Hypertens; 2008 Sep; 26(9):1742-9. PubMed ID: 18698207
[TBL] [Abstract][Full Text] [Related]
33. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I
J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756
[TBL] [Abstract][Full Text] [Related]
34. Association of Frailty and Cardiometabolic Risk Among Community-Dwelling Middle-Aged and Older People: Results from the I-Lan Longitudinal Aging Study.
Hwang AC; Liu LK; Lee WJ; Chen LY; Peng LN; Lin MH; Chen LK
Rejuvenation Res; 2015 Dec; 18(6):564-72. PubMed ID: 26556635
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
36. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study.
Meigs JB; Larson MG; Fox CS; Keaney JF; Vasan RS; Benjamin EJ
Diabetes Care; 2007 Oct; 30(10):2529-35. PubMed ID: 17586736
[TBL] [Abstract][Full Text] [Related]
37. Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic disease.
Tanne D; Tenenbaum A; Boyko V; Benderly M; Fisman EZ; Matas Z; Adler Y; Behar S
Eur J Neurol; 2009 Nov; 16(11):1217-23. PubMed ID: 19538221
[TBL] [Abstract][Full Text] [Related]
38. High-risk prescribing and incidence of frailty among older community-dwelling men.
Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Cumming RG; Handelsman DJ; McLachlan AJ; Abernethy DR; Banks E; Le Couteur DG
Clin Pharmacol Ther; 2012 Mar; 91(3):521-8. PubMed ID: 22297385
[TBL] [Abstract][Full Text] [Related]
39. CRP 1846G>A polymorphism increases risk of frailty.
Almeida OP; Norman PE; van Bockxmeer FM; Hankey GJ; Flicker L
Maturitas; 2012 Mar; 71(3):261-6. PubMed ID: 22192441
[TBL] [Abstract][Full Text] [Related]
40. Frailty and the aging male.
Morley JE; Kim MJ; Haren MT; Kevorkian R; Banks WA
Aging Male; 2005; 8(3-4):135-40. PubMed ID: 16390735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
